Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | REPL |
---|---|---|
09:32 ET | 2810 | 11.06 |
09:34 ET | 100 | 11.2 |
09:38 ET | 282 | 11.22 |
09:39 ET | 100 | 11.3 |
09:41 ET | 600 | 11.3 |
09:43 ET | 1048 | 11.325 |
09:48 ET | 500 | 11.335 |
09:50 ET | 300 | 11.36 |
09:52 ET | 687 | 11.4 |
09:54 ET | 2465 | 11.39 |
09:56 ET | 2497 | 11.255 |
09:57 ET | 1513 | 11.275 |
09:59 ET | 2171 | 11.31 |
10:01 ET | 620 | 11.37 |
10:03 ET | 2094 | 11.29 |
10:06 ET | 100 | 11.29 |
10:10 ET | 1308 | 11.275 |
10:12 ET | 206 | 11.26 |
10:14 ET | 100 | 11.24 |
10:17 ET | 1100 | 11.24 |
10:19 ET | 300 | 11.25 |
10:21 ET | 860 | 11.18 |
10:24 ET | 500 | 11.135 |
10:26 ET | 882 | 11.165 |
10:28 ET | 300 | 11.21 |
10:30 ET | 600 | 11.23 |
10:32 ET | 308 | 11.185 |
10:33 ET | 100 | 11.19 |
10:35 ET | 490 | 11.21 |
10:37 ET | 1228 | 11.22 |
10:39 ET | 3667 | 11.18 |
10:42 ET | 579 | 11.17 |
10:44 ET | 579 | 11.135 |
10:46 ET | 100 | 11.15 |
10:48 ET | 1400 | 11.195 |
10:50 ET | 3389 | 11.135 |
10:51 ET | 200 | 11.16 |
10:53 ET | 300 | 11.15 |
10:55 ET | 1088 | 11.125 |
10:57 ET | 500 | 11.07 |
11:00 ET | 1000 | 11.085 |
11:02 ET | 2510 | 11.12 |
11:04 ET | 1860 | 11.11 |
11:06 ET | 904 | 11.145 |
11:08 ET | 812 | 11.15 |
11:09 ET | 400 | 11.14 |
11:11 ET | 300 | 11.12 |
11:13 ET | 100 | 11.14 |
11:15 ET | 300 | 11.1325 |
11:18 ET | 255 | 11.12 |
11:20 ET | 100 | 11.13 |
11:22 ET | 250 | 11.13 |
11:24 ET | 728 | 11.165 |
11:27 ET | 1100 | 11.15 |
11:29 ET | 100 | 11.16 |
11:31 ET | 400 | 11.15 |
11:33 ET | 800 | 11.14 |
11:36 ET | 400 | 11.07 |
11:40 ET | 200 | 11.07 |
11:42 ET | 655 | 11.08 |
11:44 ET | 300 | 11.085 |
11:45 ET | 700 | 11.03 |
11:47 ET | 510 | 11.02 |
11:49 ET | 563 | 11.02 |
11:51 ET | 800 | 11 |
11:54 ET | 100 | 10.985 |
11:56 ET | 455 | 10.97 |
11:58 ET | 1300 | 11 |
12:00 ET | 309 | 11 |
12:02 ET | 74033 | 11.05 |
12:03 ET | 1430 | 10.99 |
12:05 ET | 628 | 10.97 |
12:07 ET | 1595 | 10.9 |
12:09 ET | 1291 | 10.87 |
12:12 ET | 2295 | 10.84 |
12:14 ET | 1759 | 10.87 |
12:18 ET | 330 | 10.88 |
12:20 ET | 9363 | 11.035 |
12:21 ET | 300 | 11.025 |
12:23 ET | 727 | 11.04 |
12:25 ET | 200 | 11.06 |
12:27 ET | 400 | 11.08 |
12:30 ET | 250 | 11.09 |
12:32 ET | 100 | 11.08 |
12:34 ET | 500 | 11.06 |
12:36 ET | 400 | 11.07 |
12:38 ET | 100 | 11.07 |
12:39 ET | 100 | 11.07 |
12:41 ET | 208 | 11.08 |
12:43 ET | 400 | 11.06 |
12:45 ET | 1199 | 11.085 |
12:48 ET | 500 | 11.105 |
12:50 ET | 400 | 11.1 |
12:54 ET | 735 | 11.07 |
12:56 ET | 1825 | 11.06 |
12:57 ET | 200 | 11.06 |
12:59 ET | 808 | 11.07 |
01:01 ET | 478 | 11.075 |
01:03 ET | 200 | 11.07 |
01:06 ET | 200 | 11.06 |
01:08 ET | 100 | 11.07 |
01:10 ET | 950 | 11.04 |
01:12 ET | 500 | 11.03 |
01:14 ET | 300 | 11.03 |
01:15 ET | 200 | 11.02 |
01:17 ET | 614 | 11.01 |
01:19 ET | 606 | 11.005 |
01:24 ET | 100 | 11.01 |
01:26 ET | 100 | 11 |
01:28 ET | 208 | 10.995 |
01:30 ET | 4533 | 10.965 |
01:35 ET | 300 | 10.99 |
01:37 ET | 100 | 10.97 |
01:39 ET | 200 | 10.98 |
01:44 ET | 1014 | 10.98 |
01:48 ET | 600 | 10.99 |
01:50 ET | 300 | 10.99 |
01:55 ET | 956 | 11 |
01:57 ET | 3206 | 10.955 |
02:00 ET | 450 | 10.97 |
02:02 ET | 200 | 10.96 |
02:04 ET | 100 | 10.965 |
02:06 ET | 237 | 10.97 |
02:08 ET | 600 | 10.92 |
02:09 ET | 500 | 10.93 |
02:11 ET | 1506 | 10.93 |
02:13 ET | 1300 | 10.93 |
02:15 ET | 1310 | 10.92 |
02:20 ET | 800 | 10.91 |
02:22 ET | 800 | 10.91 |
02:24 ET | 1450 | 10.89 |
02:26 ET | 1478 | 10.88 |
02:27 ET | 300 | 10.88 |
02:29 ET | 1141 | 10.89 |
02:31 ET | 1100 | 10.83 |
02:36 ET | 831 | 10.83 |
02:38 ET | 1276 | 10.855 |
02:40 ET | 460 | 10.87 |
02:42 ET | 410 | 10.92 |
02:44 ET | 807 | 10.89 |
02:45 ET | 202 | 10.89 |
02:47 ET | 400 | 10.9 |
02:49 ET | 100 | 10.91 |
02:51 ET | 600 | 10.91 |
02:54 ET | 520 | 10.89 |
02:56 ET | 200 | 10.88 |
02:58 ET | 100 | 10.89 |
03:00 ET | 868 | 10.85 |
03:02 ET | 1032 | 10.83 |
03:03 ET | 400 | 10.85 |
03:07 ET | 2529 | 10.85 |
03:09 ET | 572 | 10.81 |
03:12 ET | 1125 | 10.78 |
03:14 ET | 2516 | 10.71 |
03:16 ET | 1166 | 10.75 |
03:18 ET | 841 | 10.73 |
03:20 ET | 1040 | 10.76 |
03:21 ET | 300 | 10.78 |
03:23 ET | 400 | 10.8 |
03:25 ET | 508 | 10.805 |
03:27 ET | 867 | 10.82 |
03:30 ET | 3234 | 10.85 |
03:32 ET | 300 | 10.88 |
03:34 ET | 1715 | 10.86 |
03:36 ET | 238 | 10.875 |
03:38 ET | 2366 | 10.91 |
03:39 ET | 200 | 10.93 |
03:41 ET | 2698 | 10.95 |
03:43 ET | 88166 | 10.96 |
03:45 ET | 6429 | 10.97 |
03:48 ET | 51493 | 10.96 |
03:50 ET | 5369 | 10.955 |
03:52 ET | 11012 | 10.84 |
03:54 ET | 5219 | 10.87 |
03:56 ET | 3787 | 10.84 |
03:57 ET | 10808 | 10.955 |
03:59 ET | 236306 | 10.96 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Replimune Group Inc | 748.8M | -3.3x | --- |
Rapport Therapeutics Inc | 749.1M | -11.6x | --- |
Nuvation Bio Inc | 766.6M | -1.1x | --- |
Erasca Inc | 771.2M | -3.0x | --- |
Oric Pharmaceuticals Inc | 723.1M | -5.8x | --- |
89Bio Inc | 783.7M | -3.8x | --- |
Replimune Group, Inc. a clinical-stage biotechnology company engaged in the development of a novel class of oncolytic immunotherapies. The Company’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. RP1 (vusolimogene oderparepvec) is its lead product candidate and is based on a proprietary strain of herpes simplex virus engineered and genetically armed with a fusogenic protein (GALV-GP R-) and GM-CSF intended to maximize tumor killing potency, the immunogenicity of tumor cell death, and the activation of a systemic anti-tumor immune response. It is also developing additional product candidates, RP2 and RP3, to enhance anti-tumor immune responses and are intended to address additional tumor types, including traditionally less immune responsive tumor types. RP2 additionally expresses an anti-CTLA-4 antibody-like molecule, as well as GALV-GP R- and GM-CSF.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $748.8M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 68.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.21 |
EPS | $-3.27 |
Book Value | $6.10 |
P/E Ratio | -3.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.